Novo Holdings A/S Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$1.1T
Holdings
17
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VTIVANGUARD INDEX FDS | 2,155,100 | $239.9B | 21.31% | |
| 2 | INGNINOGEN INC | 3,549,320 | $212.6B | 18.88% | |
| 3 | —OPHTHOTECH CORP | 3,610,487 | $166.6B | 14.79% | |
| 4 | —COLUCID PHARMACEUTICALS INC | 3,156,563 | $120.4B | 10.69% | |
| 5 | VGKVANGUARD INTL EQUITY INDEX F | 2,101,000 | $102.4B | 9.09% | |
| 6 | RETAEURREATA PHARMACEUTICALS INC | 3,367,763 | $88.8B | 7.88% | |
| 7 | CRVSCORVUS PHARMACEUTICALS INC | 3,224,046 | $53.0B | 4.71% | |
| 8 | XLRNACCELERON PHARMA INC | 903,833 | $32.7B | 2.91% | |
| 9 | —SPECTRANETICS CORP | 1,155,722 | $29.0B | 2.58% | |
| 10 | MRUSMERUS N V | 1,410,417 | $23.6B | 2.10% | |
| 11 | —FLEXION THERAPEUTICS INC | 1,097,718 | $21.4B | 1.90% | |
| 12 | —INVUITY INC | 1,285,448 | $17.6B | 1.57% | |
| 13 | —NABRIVA THERAPEUTICS AG | 1,116,660 | $7.9B | 0.70% | |
| 14 | —WRIGHT MED GROUP N V | 4,622,032 | $6.1B | 0.54% | |
| 15 | —HTG MOLECULAR DIAGNOSTICS INC | 1,280,185 | $2.9B | 0.26% | |
| 16 | XENEXENON PHARMACEUTICALS INC | 127,563 | $1.0B | 0.09% | |
| 17 | OPKOPKO HEALTH INC | 259 | $3.0M | 0.00% |